Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ina Kramer

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Neuron|February 1, 2006
A role for Runx transcription factor signaling in dorsal root ganglion sensory neuron diversificationIna Kramer, Markus Sigrist, Joriene C de Nooij, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2014
Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levelsMing-Kang Chang, Ina Kramer, Thomas Huber, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 19, 2007
Control of the SOST bone enhancer by PTH using MEF2 transcription factorsOlivier Leupin, Ina Kramer, Nicole M Collette, et al.
Neuron|May 14, 2003
Peripheral NT3 signaling is required for ETS protein expression and central patterning of proprioceptive sensory afferentsTushar D Patel, Ina Kramer, Jan Kucera, et al.
Journal of the Royal Society, Interface|April 20, 2018
<i>Sost</i> deficiency leads to reduced mechanical strains at the tibia midshaft in strain-matched <i>in vivo</i> loading experiments in miceLaia Albiol, Myriam Cilla, David Pflanz, et al.
Genesis (New York, N.Y. : 2000)|November 8, 2007
Characterization of a thy1.2 GFP transgenic mouse reveals a tissue-specific organization of the spinal dorsal hornMino D Belle, Edward F Pattison, Ornsiri Cheunsuang, et al.
Bone|May 3, 2017
Combination sclerostin antibody and zoledronic acid treatment outperforms either treatment alone in a mouse model of osteogenesis imperfectaDavid G Little, Lauren Peacock, Kathy Mikulec, et al.
Bioorganic & Medicinal Chemistry Letters|March 11, 2022
Discovery of a novel 2-aminopyrazine-3-carboxamide as a potent and selective inhibitor of Activin Receptor-Like Kinase-2 (ALK2) for the treatment of fibrodysplasia ossificans progressivaThomas Ullrich, Luca Arista, Sven Weiler, et al.
Calcified Tissue International|May 31, 2018
Dkk1 KO Mice Treated with Sclerostin Antibody Have Additional Increases in Bone VolumeAlyson Morse, Tegan L Cheng, Aaron Schindeler, et al.
Bone|October 28, 2009
Ubiquitous overexpression of Hey1 transcription factor leads to osteopenia and chondrocyte hypertrophy in boneRishard Salie, Michaela Kneissel, Mirko Vukevic, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Neuron|February 1, 2006
A role for Runx transcription factor signaling in dorsal root ganglion sensory neuron diversificationIna Kramer, Markus Sigrist, Joriene C de Nooij, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2014
Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levelsMing-Kang Chang, Ina Kramer, Thomas Huber, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 19, 2007
Control of the SOST bone enhancer by PTH using MEF2 transcription factorsOlivier Leupin, Ina Kramer, Nicole M Collette, et al.
Neuron|May 14, 2003
Peripheral NT3 signaling is required for ETS protein expression and central patterning of proprioceptive sensory afferentsTushar D Patel, Ina Kramer, Jan Kucera, et al.
Journal of the Royal Society, Interface|April 20, 2018
<i>Sost</i> deficiency leads to reduced mechanical strains at the tibia midshaft in strain-matched <i>in vivo</i> loading experiments in miceLaia Albiol, Myriam Cilla, David Pflanz, et al.
Genesis (New York, N.Y. : 2000)|November 8, 2007
Characterization of a thy1.2 GFP transgenic mouse reveals a tissue-specific organization of the spinal dorsal hornMino D Belle, Edward F Pattison, Ornsiri Cheunsuang, et al.
Bone|May 3, 2017
Combination sclerostin antibody and zoledronic acid treatment outperforms either treatment alone in a mouse model of osteogenesis imperfectaDavid G Little, Lauren Peacock, Kathy Mikulec, et al.
Bioorganic & Medicinal Chemistry Letters|March 11, 2022
Discovery of a novel 2-aminopyrazine-3-carboxamide as a potent and selective inhibitor of Activin Receptor-Like Kinase-2 (ALK2) for the treatment of fibrodysplasia ossificans progressivaThomas Ullrich, Luca Arista, Sven Weiler, et al.
Calcified Tissue International|May 31, 2018
Dkk1 KO Mice Treated with Sclerostin Antibody Have Additional Increases in Bone VolumeAlyson Morse, Tegan L Cheng, Aaron Schindeler, et al.
Bone|October 28, 2009
Ubiquitous overexpression of Hey1 transcription factor leads to osteopenia and chondrocyte hypertrophy in boneRishard Salie, Michaela Kneissel, Mirko Vukevic, et al.
Pageof 5